nsv4716235
- Organism: Homo sapiens
- Study:nstd195 (Mwapagha et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37 (hg19)
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:2
- Publication(s):Mwapagha et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 158 SVs from 41 studies. See in: genome view
Overlapping variant regions from other studies: 485 SVs from 54 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4716235 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | Second Pass | NC_000010.11 | Chr10 | 50,185,652 | 50,185,653 |
| nsv4716235 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000010.10 | Chr10 | 48,000,115 | 48,000,116 |
Variant Call Information
| Variant Call ID | Type | Sample ID | Method | Analysis | Copy number | Other Calls in this Sample and Study |
|---|---|---|---|---|---|---|
| nssv16249244 | inversion | B381 | Sequencing | Paired-end mapping | 1 | 5,743 |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16249244 | Remapped | Perfect | NC_000010.11:g.501 85652_50185653inv | GRCh38.p12 | Second Pass | NC_000010.11 | Chr10 | 50,185,652 | 50,185,653 |
| nssv16249244 | Submitted genomic | NC_000010.10:g.480 00115_48000116inv | GRCh37 (hg19) | NC_000010.10 | Chr10 | 48,000,115 | 48,000,116 |